You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (48)

Journals (0)

1-10 of 48 results for gemcitabine/nab-paclitaxel

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma

Retricted access

Research article

First published 2020-4

Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma

María-José Nebot-Villacampa, Ricardo Zafra-Morales, Ascensión Alfaro-Olea [...]

Journal of Oncology Pharmacy Practice

Select article: A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

Free access

Research article

First published 2017-2

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

Daniel H. Ahn, Kavya Krishna, Marlo Blazer [...]

Therapeutic Advances in Medical Oncology

Select article: A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study

Open access

Research article

First published 2022-11

A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study

Chen Chang, Lingwei Meng, Xiaofen Li [...]

Cancer Control

Select article: Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Open access

Research article

First published 2021

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang [...]

Therapeutic Advances in Medical Oncology

Select article: Use of nab -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience

Retricted access

Research article

First published 2022-10

Use of nab -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience

Angela Chen, Vincent H Ha, Sunita Ghosh [...]

Journal of Oncology Pharmacy Practice

Select article: Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Open access

Research article

First published 2020

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Heejung Chae, Hyehyun Jeong, Jaekyung Cheon [...]

Therapeutic Advances in Medical Oncology

Select article: Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter,single-arm,open-label,phase 2 trial

Open access

Research article

First published 2021

Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter,single-arm,open-label,phase 2 trial

Gunn Huh, Hee Seung Lee, Jin Ho Choi [...]

Therapeutic Advances in Medical Oncology

Select article: Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Open access

Research article

First published 2019

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Nicolas Williet, Angélique Saint, Anne-Laure Pointet [...]

Therapeutic Advances in Gastroenterology

Select article: The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter,noninterventional study

Open access

Research article

First published 2020

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter,noninterventional study

Jakob Michael Riedl, Florian Posch, Gerald Prager [...]

Therapeutic Advances in Medical Oncology

Select article: Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study

Open access

Research article

First published 2026

Gemcitabine/nab-paclitaxel plus S-1 combination compared with gemcitabine/nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: a retrospective study

Kuan-Yu Tseng, Chiann-Yi Hsu, Cheng-Han Wu [...]

Therapeutic Advances in Medical Oncology

1
2
3
4
5
10 / page

Article type

Publication date

Subjects

Access